ORGS - EXCLUSIVE: Orgenesis Acquires Control of Octomera Takes One Step Closer To Progressing Its Decentralized Immuno-Oncology Portfolio To Clinic | Benzinga
Orgenesis Inc (NASDAQ:ORGS) has entered into a definitive agreement with MM OS Holdings, an affiliate of Metalmark Capital Partners, to acquire its approximate 25% stake in Octomera.
Octomera is Orgenesis’s cell processing services subsidiary, and the transaction allows the company to have 100% ownership of this business unit.
In exchange, Metalmark will receive a royalty ...